Exelixis
EXEL · Large Cap · NYSE · Healthcare · Biotechnology
$64.53−$0.78 (-1.19%)
Market closed · opens in 1d 0hNext open: Monday, Oct 26, 9:30 AM ETFree AI brief
Get the full brief on EXEL
Free to track. No card required. Usually ready in 10-15 minutes.
Where EXEL sits today
Price, momentum, and the numbers behind the story.
52-week range
Low$33.76
High$57.57
Today $64.53
RSI (14)
70.7Overbought
03070100
Stocksbrew score
69/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
- ✓5 years of revenue, profit and cash flow
- ✓Valuation and balance-sheet checks
- ✓Business and geographic mix
- ✓Analyst targets and recommendation trend
Free for 3 days, then $9/mo. Cancel anytime.
What Wall Street thinks
Where the analysts and the crowd stand, and what it's worth to know first.
Analyst price targets
Lowest
$41
Median target
$54
Current price
$64.53
Highest
$70
LowHigh
The business, by the numbers
What it earns and where it earns it, what you're paying for the stock, and the risk sitting on the balance sheet.
RevenueTrend
✓ Good things about the company
Forward P/E
Favorable · 28% below avg
18.36x
Price / FCF
Strong · Cash flow supports price
13.64x
ROIC
Strong · Excellent capital returns
66.0%
ROE
Favorable · 41.0% - strong capital efficiency
44.4%
Debt / equity
Favorable · 0.09 - strong leverage
0.09x
Current ratio
Strong · Good liquidity position
3.46x
How it stacks up against its peers
EXEL against the names it's actually compared to.
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $15.99B | 20.3 | +9.2% | 69 |
 | $10.93B | 20.8 | +19.7% | 78 |
 | $29.41B | 30.8 | +15.5% | 78 |
 | $4.30B | 12.2 | +13.5% | 78 |
 | $1.20T | 43.3 | +49.6% | 77 |